| Linda A. Evans, Ph.d., Pa | |
|
101 N Ocean Dr Suite 212 Hollywood FL 33019-1728 | |
| (954) 699-9660 | |
| (964) 921-9126 |
| Full Name | Linda A. Evans, Ph.d., Pa |
|---|---|
| Speciality | Psychologist |
| Location | 101 N Ocean Dr, Hollywood, Florida |
| Authorized Official Name and Position | Linda Ann Evans (LICENSED PSYCHOLOGIST/OWNER) |
| Authorized Official Contact | 9546999660 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Linda A. Evans, Ph.d., Pa 101 N Ocean Dr Suite 212 Hollywood FL 33019-1728 Ph: (954) 699-9660 | Linda A. Evans, Ph.d., Pa 101 N Ocean Dr Suite 212 Hollywood FL 33019-1728 Ph: (954) 699-9660 |
| NPI Number | 1902998131 |
|---|---|
| Provider Enumeration Date | 09/28/2006 |
| Last Update Date | 09/29/2008 |
| Medicare PECOS PAC ID | 1658379664 |
|---|---|
| Medicare Enrollment ID | O20061129000087 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that OSI Electronics, a business within its Optoelectronic and Manufacturing division, has received an order of approximately $4 million for electronic sub-assemblies from an innovative medical device manufacturer.
Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with co-principal investigator, Sung-Yun Pai, MD, of Boston Children's Hospital, has been awarded nearly $9 million from the National Institute of Allergy and Infectious Diseases of the NIH to study a new treatment approach for babies born with severe combined immunodeficiency (SCID) which prevents the immune system from functioning normally.
Most people with allergies have to take medication throughout their life: Their body "thinks" that proteins from the environment are so "strange" that they elicit an immune reaction. Until present, it was not possible to develop an efficient therapy so that the body "learns" to stop in an overreacting way.
Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, announced today that results from a new study presented at the virtual 2020 meeting of the American Society of Clinical Oncology suggest that circulating tumor cell counts may be useful in determining long-term prognosis and guiding treatment selection in patients with metastatic castrate sensitive prostate cancer.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902998131 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | (* (Not Available)) | Primary |
| Provider Name | Linda A Evans |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1780698944 PECOS PAC ID: 9830115369 Enrollment ID: I20051024000316 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that OSI Electronics, a business within its Optoelectronic and Manufacturing division, has received an order of approximately $4 million for electronic sub-assemblies from an innovative medical device manufacturer.
Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with co-principal investigator, Sung-Yun Pai, MD, of Boston Children's Hospital, has been awarded nearly $9 million from the National Institute of Allergy and Infectious Diseases of the NIH to study a new treatment approach for babies born with severe combined immunodeficiency (SCID) which prevents the immune system from functioning normally.
Most people with allergies have to take medication throughout their life: Their body "thinks" that proteins from the environment are so "strange" that they elicit an immune reaction. Until present, it was not possible to develop an efficient therapy so that the body "learns" to stop in an overreacting way.
Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, announced today that results from a new study presented at the virtual 2020 meeting of the American Society of Clinical Oncology suggest that circulating tumor cell counts may be useful in determining long-term prognosis and guiding treatment selection in patients with metastatic castrate sensitive prostate cancer.
› Verified 2 days ago
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that OSI Electronics, a business within its Optoelectronic and Manufacturing division, has received an order of approximately $4 million for electronic sub-assemblies from an innovative medical device manufacturer.
Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with co-principal investigator, Sung-Yun Pai, MD, of Boston Children's Hospital, has been awarded nearly $9 million from the National Institute of Allergy and Infectious Diseases of the NIH to study a new treatment approach for babies born with severe combined immunodeficiency (SCID) which prevents the immune system from functioning normally.
Most people with allergies have to take medication throughout their life: Their body "thinks" that proteins from the environment are so "strange" that they elicit an immune reaction. Until present, it was not possible to develop an efficient therapy so that the body "learns" to stop in an overreacting way.
Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, announced today that results from a new study presented at the virtual 2020 meeting of the American Society of Clinical Oncology suggest that circulating tumor cell counts may be useful in determining long-term prognosis and guiding treatment selection in patients with metastatic castrate sensitive prostate cancer.
› Verified 2 days ago
South Broward Hospital District Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1150 N 35th Ave Ste 525, Hollywood, FL 33021 Phone: 954-265-6966 Fax: 954-265-6950 | |
Reclamation Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6966 Taft St, Hollywood, FL 33024 Phone: 954-432-8831 Fax: 954-432-8832 | |
Our Children Our Future, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 450 N Park Rd, Suite 600, Hollywood, FL 33021 Phone: 954-929-7515 Fax: 954-929-7510 | |
Serenity Behavioral Health Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2303 Hollywood Blvd, Suite 12, Hollywood, FL 33020 Phone: 954-367-7944 Fax: 954-374-8311 | |
My Choice Individual And Family Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2900 Dorchester Ln, Hollywood, FL 33026 Phone: 954-864-4552 | |
Live Free Wellness Institute Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7709 Davie Road Ext, Hollywood, FL 33024 Phone: 305-336-1739 | |
Goddess Health & Wellness, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5420 Hollywood Blvd Apt 111, Hollywood, FL 33021 Phone: 754-300-7591 Fax: 954-206-0496 |